FENC icon

Fennec Pharmaceuticals
FENC

Overview Fund Activity

29 hedge funds and large institutions have $56.3M invested in Fennec Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 7 closing their positions.

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.64%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
6
Increased
5
Reduced
9
Closed
7
Calls
$115K
Puts
–
Net Calls
+$115K
Net Calls Change
+$115K

Top Buyers

1
CCM
1
Cadence Capital Management
Massachusetts
$874K
2
OAM
2
Oxford Asset Management
United Kingdom
$770K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$452K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$526K
5
Millennium Management
5
Millennium Management
New York
$114K

Top Sellers

1
GIM
1
Granahan Investment Management
Massachusetts
$1.61M
2
PP
2
Paloma Partners
Connecticut
$0
3
OM
3
Opaleye Management
Massachusetts
$0
4
SCM
4
Solas Capital Management
Connecticut
$5.7M
5
WQ
5
Wealth Quarterback
New Jersey
$5.94K
Name Holding Trade Value Shares
Change 		Shares
Change %
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$14 – – –
PP
27
Paloma Partners
Connecticut
– -$143K -22,026 Closed
OM
28
Opaleye Management
Massachusetts
– -$78K -12,000 Closed
Deutsche Bank
29
Deutsche Bank
Germany
– -$9K -1,393 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– -$7K -1,163 Closed
UBS Group
31
UBS Group
Switzerland
– -$6K -983 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$3K -400 Closed
PCM
33
Prelude Capital Management
New York
– -$2K -244 Closed
1
2